Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 1c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Zimmer Biomet's (ZBH) strong second quarter tarnished by high expectations
August 1, 2023 12:13 PM EDTShares of medical technology company Zimmer Biomet (NYSE: ZBH) declined after it reported results for the second quarter of 2023. Revenue, earnings per share, and guidance all topped published consensus figures but they were still not enough to meet elevated expectations on Wall Street.
Zimmer Biomet reported second quarter EPS of 1.82, a... More
